Jacob Thaysen
CEO, President & DirectorMr. Jacob Thaysen, Ph.D., serves as Chief Executive Officer of Illumina, Inc. since September 25, 2023 and serves as its Director since September 2023 and also serves as its President. He served as Interim Chief Commercial Officer at Illumina, Inc. from 2026 until July 20, 2026. Prior to joining Illumina, Inc. in 2023, Thaysen served as president of the Life Sciences and Applied Markets Group and Diagnostic and Genomics Group at Agilent; corporate vice president of R&D at Dako; and management consultant at Copenhagen Consultancy Company (now Bain & Co). Early in his career, he was founder and chief technology officer of Cantion, a research and defense application development company based in Denmark. Thaysen is Chairman of the ALDA Board (Analytical, Life Science and Diagnostic Association) and is a San Diego Chapter member of the American Cancer Society’s CEOs Against Cancer. Thaysen holds an MSc and PhD in physics from the Technical University of Denmark.
公司职务
- 公司名称Illumina, Inc.股票代码ILMN职务CEO, President & Director共事同僚
- SGScott GottliebIndependent Chairman
- ADAnkur DhingraChief Financial Officer
- KCKevin Carl PegelsChief of Global Operations
- SBSteven BarnardChief Technology Officer
- SEScott EricksenVP & Chief Accounting Officer
- SESusan E. SiegelIndependent Director
- SBScott B. UllemIndependent Director
- ASAnna S. RichoIndependent Director
